JULIO ALBERTO RAMIREZ

Summary

Affiliation: University of Louisville
Country: USA

Publications

  1. ncbi Switch therapy in hospitalized patients with community-acquired pneumonia: tigecycline vs. levofloxacin
    Julio A Ramirez
    University of Louisville, Louisville, KY 40202, USA
    BMC Infect Dis 12:159. 2012
  2. ncbi Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study
    Julie E Mangino
    The Ohio State University, 410 West 10th Ave, N 1150 Doan Hall Columbus, OH 43210, USA
    Crit Care 15:R38. 2011
  3. ncbi Changing needs of community-acquired pneumonia
    JULIO ALBERTO RAMIREZ
    Infectious Diseases, University of Louisville, KY 40202, USA
    J Antimicrob Chemother 66:iii3-9. 2011
  4. ncbi The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia
    S Aliberti
    Dipartimento Toraco polmonare e Cardio circolatorio, University of Milan, Milan, Italy
    Int J Tuberc Lung Dis 13:1550-6. 2009
  5. ncbi Acute myocardial infarction in hospitalized patients with community-acquired pneumonia
    Julio Ramirez
    Divisions of Infectious Diseases, University of Louisville and Veterans Administration, Louisville, Kentucky 40202, USA
    Clin Infect Dis 47:182-7. 2008
  6. ncbi Fostering international multicenter collaborative research: the CAPO Project
    J A Ramirez
    Department of Veterans Affairs Medical Center, University of Louisville, Louisville, Kentucky 40202, USA
    Int J Tuberc Lung Dis 11:1062-5. 2007
  7. ncbi Controlling multiple-drug-resistant organisms at the hospital level
    Julio A Ramirez
    Division of Infectious Diseases, University of Louisville, 512 South Hancock Street, Carmichael Building, Room 208 D, Louisville, KY 40202, USA
    Expert Opin Pharmacother 7:1449-55. 2006
  8. ncbi Worldwide perspective of the quality of care provided to hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study
    Julio A Ramirez
    Division of Infectious Diseases, Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA
    Semin Respir Crit Care Med 26:543-52. 2005
  9. ncbi Multicenter, multinational observational studies: a new approach to studying community-acquired pneumonia
    Julio Ramirez
    Division of Infectious Diseases, Department of Medicine, University of Louisville School of Medicine, 323 East Chestnut, Louisville, KY 40202, USA
    Respir Care Clin N Am 11:35-44. 2005
  10. ncbi Processes of care for community-acquired pneumonia
    Julio A Ramirez
    Division of Infectious Diseases, Department of Medicine, University of Louisville, 512 South Hancock Street, Carmichael Building, Room 208 D, Louisville, KY 40202, USA
    Infect Dis Clin North Am 18:843-59. 2004

Collaborators

Detail Information

Publications21

  1. ncbi Switch therapy in hospitalized patients with community-acquired pneumonia: tigecycline vs. levofloxacin
    Julio A Ramirez
    University of Louisville, Louisville, KY 40202, USA
    BMC Infect Dis 12:159. 2012
    ..This analysis compares switch therapy using tigecycline versus levofloxacin in hospitalized patients with community-acquired pneumonia (CAP)...
  2. ncbi Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study
    Julie E Mangino
    The Ohio State University, 410 West 10th Ave, N 1150 Doan Hall Columbus, OH 43210, USA
    Crit Care 15:R38. 2011
    ..Our objectives were to develop and implement the project, and to assess compliance with quality indicators in adults admitted to intensive care units (ICUs) with HAP, VAP, or HCAP...
  3. ncbi Changing needs of community-acquired pneumonia
    JULIO ALBERTO RAMIREZ
    Infectious Diseases, University of Louisville, KY 40202, USA
    J Antimicrob Chemother 66:iii3-9. 2011
    ..pneumoniae and MRSA are needed for the management of patients with CAP...
  4. ncbi The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia
    S Aliberti
    Dipartimento Toraco polmonare e Cardio circolatorio, University of Milan, Milan, Italy
    Int J Tuberc Lung Dis 13:1550-6. 2009
    ..The ability of the pneumonia severity index (PSI) and the CRB-65 to identify patients with low vs. high risk for mortality among cancer patients with CAP has not been evaluated...
  5. ncbi Acute myocardial infarction in hospitalized patients with community-acquired pneumonia
    Julio Ramirez
    Divisions of Infectious Diseases, University of Louisville and Veterans Administration, Louisville, Kentucky 40202, USA
    Clin Infect Dis 47:182-7. 2008
    ..The objective of this study was to investigate the association of AMI with the severity of pneumonia at hospitalization and clinical failure during hospitalization among patients with CAP...
  6. ncbi Fostering international multicenter collaborative research: the CAPO Project
    J A Ramirez
    Department of Veterans Affairs Medical Center, University of Louisville, Louisville, Kentucky 40202, USA
    Int J Tuberc Lung Dis 11:1062-5. 2007
    ..Investigators may be interested in joining the CAPO research team or applying the CAPO model for international collaboration to other areas of clinical research...
  7. ncbi Controlling multiple-drug-resistant organisms at the hospital level
    Julio A Ramirez
    Division of Infectious Diseases, University of Louisville, 512 South Hancock Street, Carmichael Building, Room 208 D, Louisville, KY 40202, USA
    Expert Opin Pharmacother 7:1449-55. 2006
    ..Without achieving these three goals, hospitals will not be able to control the spread of MDR organisms...
  8. ncbi Worldwide perspective of the quality of care provided to hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study
    Julio A Ramirez
    Division of Infectious Diseases, Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA
    Semin Respir Crit Care Med 26:543-52. 2005
    ..New interventions to advance quality of care are necessary to improve clinical and economic outcomes in CAP...
  9. ncbi Multicenter, multinational observational studies: a new approach to studying community-acquired pneumonia
    Julio Ramirez
    Division of Infectious Diseases, Department of Medicine, University of Louisville School of Medicine, 323 East Chestnut, Louisville, KY 40202, USA
    Respir Care Clin N Am 11:35-44. 2005
    ..By closing the gap between clinical research and clinical practice, the management of patients with CAP will improve worldwide...
  10. ncbi Processes of care for community-acquired pneumonia
    Julio A Ramirez
    Division of Infectious Diseases, Department of Medicine, University of Louisville, 512 South Hancock Street, Carmichael Building, Room 208 D, Louisville, KY 40202, USA
    Infect Dis Clin North Am 18:843-59. 2004
    ..Having an unambiguous action plan helps to develop process-of-care indicators and to educate healthcare workers. Improving processes of care is a secure way to improve outcomes in hospitalized patients with CAP...
  11. ncbi Community-acquired pneumonia in adults
    Julio A Ramirez
    Department of Medicine, University of Louisville School of Medicine, Department of Veterans Affairs Medicine Center, Louisville, KY, USA
    Prim Care 30:155-71. 2003
    ..The use of pneumococcal vaccine, influenza vaccine, and smoking-cessation programs is an important strategy to prevent CAP...
  12. ncbi Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia
    J A Ramirez
    Division of Infectious Diseases, Department of Medicine, University of Louisville, Louisville, KY 40292, USA
    Arch Intern Med 161:848-50. 2001
    ..The identification of Streptococcus pneumoniae bacteremia in hospitalized patients with community-acquired pneumonia is considered by some investigators to be an exclusion criterion for early switch from intravenous to oral therapy...
  13. ncbi Interactions of Chlamydia pneumoniae with human endothelial cells
    J T Summersgill
    Division of Infectious Diseases, Dept of Medicine, University of Louisville School of Medicine, Louisville, KY 40292, USA
    J Infect Dis 181:S479-82. 2000
    ..pneumoniae can infect human endothelial cells and induce the expression of many molecules that are important mediators of atherogenesis including cytokines, adhesion molecules, chemokines, and molecules with procoagulant activity...
  14. ncbi Signal transduction during Legionella pneumophila entry into human monocytes
    P Y Coxon
    Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky 40292, USA
    Infect Immun 66:2905-13. 1998
    ..Therefore, the tyrosine-induced phosphorylation observed during opsonized L. pneumophila entry is not a virulence-associated event...
  15. ncbi Managing antiinfective therapy of community-acquired pneumonia in the hospital setting: focus on switch therapy
    J A Ramirez
    Department of Medicine, University of Louisville School of Medicine, Kentucky 40292, USA
    Pharmacotherapy 21:79S-82S. 2001
    ..Universal use of switch therapy in the United States could result in the total reduction of about 440,000 hospital days annually and an overall savings of $400 million...
  16. ncbi Erythrocytic glutathione and plasma cysteine status of human immunodeficient patients
    C A Lang
    Department of Biochemistry, University of Louisville School of Medicine, Louisville, KY 40292, USA
    Exp Biol Med (Maywood) 226:866-9. 2001
    ..However, the Cys contents were higher in patients than in controls (P < 0.05). These findings demonstrated that HIV patients have normal erythrocytic GSH concentrations and supranormal Cys levels...
  17. ncbi The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia
    S Aliberti
    Institute of Respiratory Disease, University of Milan, Ospedale Maggiore Fondazione IRCCS Policlinico, Mangiagalli e Regina Elena, Milan, Italy
    Eur Respir J 33:142-7. 2009
    ..30). Lack of neutropenia, during the initial evaluation of a cancer community-acquired pneumonia patient, should not be considered an indicator of better clinical outcome...
  18. ncbi Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
    S Aliberti
    Dipartimento Toraco polmonare e Cardio circolatorio, University of Milan, Milan, Italy
    Eur Respir J 36:128-34. 2010
    ..Duration of therapy is not influenced by either the severity of disease at the time of hospitalisation or the clinical response to therapy...
  19. ncbi Inhibition of oxidative burst and chemotaxis in human phagocytes by Legionella pneumophila zinc metalloprotease
    N N Sahney
    Department of Microbiology and Immunology, School of Medicine, University of Louisville, KY 40292, USA
    J Med Microbiol 50:517-25. 2001
    ..These results suggest that the L. pneumophila Msp protease alters human phagocyte functional responses significantly and may contribute to the pathogenesis of Legionnaires' disease...
  20. ncbi Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon
    L G Pantoja
    Division of Infectious Diseases, Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky 40292, USA
    Infect Immun 69:7927-32. 2001
    ..Ultrastructural analysis of IFN-gamma-treated C. pneumoniae revealed atypical inclusions containing large reticulatate-like aberrant bodies with no evidence of redifferentiation into elementary bodies...
  21. ncbi Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia
    Mehdi Mirsaeidi
    Division of Infectious Diseases, Department of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
    Chest 137:416-20. 2010
    ..The objectives of this study were to evaluate if abnormal platelet count in hospitalized patients with CAP was associated with 30-day mortality and to compare platelet count and leukocyte count as predictors of 30-day mortality...